Merck & Co.

AWARDS

NEWS

Biotech Beach

The Day In Review: Amgen Buys Avidia, Inc. For $290 Million

October 3, 2006

·

1 min read

Biotech Bay

The Day In Review: Amgen Gets Approval For Vectibix

September 27, 2006

·

1 min read

Policy

FDA Seen Needing To Fix Post-Market Drug Safety

September 25, 2006

·

1 min read

The Day In Review: Merck & Co., Inc. Gets European Approval Of Gardasil

September 23, 2006

·

1 min read

The Day In Review: Advanced Cell Therapeutics Makes Stem Cell Breakthrough

August 24, 2006

·

1 min read

Biotech Beach

The Day In Review: Eli Lilly and Company Gets Approvable Letter For Arxxant

August 18, 2006

·

1 min read

JOBS

IN THE PRESS

Press Releases

Olatec Therapeutics Presented Preclinical Evidence of Disease-Modifying Activity with Dapansutrile in its Parkinson’s Studies

January 21, 2026

·

5 min read

Press Releases

Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection

January 20, 2026

·

63 min read

Press Releases

Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform

January 19, 2026

·

3 min read

Press Releases

Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

January 13, 2026

·

3 min read

Press Releases

FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

January 13, 2026

·

6 min read

Press Releases

Merck Initiates Phase 3 KANDLELIT-007 Trial Evaluating Calderasib (MK-1084), an Investigational Oral KRAS G12C Inhibitor, in Combination With KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) in Certain Patients With Advanced NSCLC

January 7, 2026

·

19 min read

Press Releases

Merck to Complete Acquisition of Cidara Therapeutics

January 7, 2026

·

6 min read

Press Releases

Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3

January 7, 2026

·

3 min read

Press Releases

Merck to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 5, 2026

·

3 min read

Press Releases

BioInvent Reports Promising Data from Ongoing Phase 2a study for BI-1808 with KEYTRUDA(R) (pembrolizumab) in Recurrent Ovarian Cancer

January 5, 2026

·

7 min read